Syros Pharmaceuticals Inc (SYRS) USD0.001
0.03%- This stock can be held in a
Stocks and Shares ISASell:$4.97
Buy:$5.00
Change:
$0.04 (0.80%)
$0.04 (0.80%)Market closed | Prices delayed by at least 15 minutes
Sell:$4.97
Buy:$5.00
Change:$0.04 (0.80%)
$0.04 (0.80%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 April 2024 | David A RothOther Level A | Sell Regular sell transaction (market) | 10,451 | $4.95 | $51,732.45 | 0 |
| 2 April 2024 | David A RothOther Level A | Sell Option/Award related | 150 | $4.98 | $747.05 | 10,451 |
| 1 April 2024 | Nancy A SimonianPresident/CEO | Sell Tax related | 14,052 | $5.12 | $71,946.24 | 131,658 |
| 1 April 2024 | Kristin StephensChief Level Officer | Sell Tax related | 4,218 | $5.12 | $21,596.16 | 25,237 |
| 1 April 2024 | Jason HaasCFO | Sell Tax related | 4,732 | $5.12 | $24,227.84 | 24,552 |
| 1 April 2024 | Conley CheeChief Legal/Compliance Officer | Sell Tax related | 3,500 | $5.12 | $17,920.00 | 22,504 |
| 1 April 2024 | David A RothOther Level A | Sell Tax related | 4,732 | $5.12 | $24,227.84 | 10,601 |
| 28 March 2024 | Gerald E QuirkChief Level Officer | Sell Tax related | 7,046 | $5.59 | $39,387.14 | 39,757 |
| 21 December 2023 | SAMSARA BIOCAPITAL LPVenture Capital | Buy Regular purchase transaction | 904,977 | $4.42 | $3,999,998.34 | 1,786,427 |
| 12 December 2023 | David A RothOther Level A | Sell Regular sell transaction (market) | 6,287 | $4.95 | $31,120.65 | 0 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 21 December 2023 | SAMSARA BIOCAPITAL LPVenture Capital | Buy Regular purchase transaction | 904,977 | $4.42 | $3,999,998.34 | 1,786,427 |
| 1 April 2024 | Nancy A SimonianPresident/CEO | Sell Tax related | 14,052 | $5.12 | $71,946.24 | 131,658 |
| 3 April 2024 | David A RothOther Level A | Sell Regular sell transaction (market) | 10,451 | $4.95 | $51,732.45 | 0 |
| 28 March 2024 | Gerald E QuirkChief Level Officer | Sell Tax related | 7,046 | $5.59 | $39,387.14 | 39,757 |
| 12 December 2023 | David A RothOther Level A | Sell Regular sell transaction (market) | 6,287 | $4.95 | $31,120.65 | 0 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.